Full Text View
Tabular View
No Study Results Posted
Related Studies
Open Label Arimidex in Gynecomastia
This study has been completed.
Study NCT00241436   Information provided by AstraZeneca
First Received: October 17, 2005   Last Updated: January 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gynecomastia
More general conditions related to this trial
Breast Diseases
Skin Diseases
Interventions listed in this trial
Anastrozole (ARIMIDEX™)
Additional drug interventions recognized in this trial
Anastrozole
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services